GL1X · GenesisL1 explorer

Research workbench

Crystal structure analysis of a human lysozyme mutant W64C C65A

Analyse Crystal structure analysis of a human lysozyme mutant W64C C65A in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1QSW
Type
protein
Length
520 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Human lysozyme mutant
UniProt
P61626
Pockets
7 · best druggability 0.72

Structure

x-ray diffraction · 1 distinct chain · 42% helix, 9% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, B, C, DHuman lysozyme mutantprotein13042% helix, 9% strandP61626

Pockets

7 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12950.720.8536empty
23730.690.8232empty
31200.510.8235empty
41020.370.7518empty
5930.370.7514empty

Interfaces

3 interfaces between chains.

  • B–C · 666 Ų buried · 8 hydrogen bonds · protein-protein
  • B–D · 469 Ų buried · 7 hydrogen bonds · protein-protein
  • A–C · 404 Ų buried · 10 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 16 disulfide (disulfide).

Compared structures

  • 1QSW · Crystal structure analysis of a human lysozyme mutant W64C C65A · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.